IL-12 and IFN-γ are required for initiating the protective th1 response to pulmonary cryptococcosis in resistant C.B-17 mice

被引:128
作者
Hoag, KA
Lipscomb, MF
Izzo, AA
Street, NE
机构
[1] Univ Texas, SW Med Ctr, Dept Microbiol, Ctr Canc Immunobiol, Dallas, TX 75235 USA
[2] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA
关键词
D O I
10.1165/ajrcmb.17.6.2879
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A murine model was used to assess the role of cytokines in initiating protective T-cell-mediated immunity in the lung, A pulmonary infection was initiated by intratracheal inoculation of Cryptococcus neoformans (Cne). Previously, we had established that Cne lung clearance was mouse-strain-specific: C.B-17 mice were resistant and developed a Th1-like response, whereas C57BL/6 mice were susceptible and did not develop a Th1 response. In the present study we showed that monoclonal anti-interferon-gamma (IFN-gamma) and anti-interleukin-12 (IL-12) antibody administration prior to infection of resistant C.B-17 mice inhibited lung clearance of Cne. Cytokine profiles of lung and lung-associated lymph nodes (LALN) from monoclonal antibody (mAb)-treated C.B-17 mice were switched from Th1-like to Th2-like, and mAb-treated C.B-17 mice exhibited lung eosinophilia, which was absent in control C.B-17 mice. Additionally, C.B-17 mice treated with anti-IFN-gamma and anti-IL-12 mAb demonstrated a significantly lower percentage of lung macrophages expressing inducible nitric oxide synthase (iNOS) than did control mice. These studies clearly demonstrate that both IFN-gamma and IL-12 are required for initiation of a Th1 response in resistant C.B-17 mice.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 30 条
[1]   INHIBITION OF CRYPTOCOCCUS-NEOFORMANS REPLICATION BY NITROGEN-OXIDES SUPPORTS THE ROLE OF THESE MOLECULES AS EFFECTORS OF MACROPHAGE-MEDIATED CYTOSTASIS [J].
ALSPAUGH, JA ;
GRANGER, DL .
INFECTION AND IMMUNITY, 1991, 59 (07) :2291-2296
[2]  
CASTRO AG, 1995, J IMMUNOL, V155, P2013
[3]   KILLING OF VIRULENT MYCOBACTERIUM-TUBERCULOSIS BY REACTIVE NITROGEN INTERMEDIATES PRODUCED BY ACTIVATED MURINE MACROPHAGES [J].
CHAN, J ;
XING, Y ;
MAGLIOZZO, RS ;
BLOOM, BR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (04) :1111-1122
[4]   CYTOKINE TREATMENT OF CENTRAL-NERVOUS-SYSTEM INFECTION - EFFICACY OF INTERLEUKIN-12 ALONE AND SYNERGY WITH CONVENTIONAL ANTIFUNGAL THERAPY IN EXPERIMENTAL CRYPTOCOCCOSIS [J].
CLEMONS, KV ;
BRUMMER, E ;
STEVENS, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :460-464
[5]   ENCAPSULATION OF CRYPTOCOCCUS-NEOFORMANS IMPAIRS ANTIGEN-SPECIFIC T-CELL RESPONSES [J].
COLLINS, HL ;
BANCROFT, GJ .
INFECTION AND IMMUNITY, 1991, 59 (11) :3883-3888
[6]  
DIAMOND RD, 1990, PRINCIPLES PRACTICE
[7]   EARLY INTERLEUKIN-12 PRODUCTION BY MACROPHAGES IN RESPONSE TO MYCOBACTERIAL INFECTION DEPENDS ON INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR-ALPHA [J].
FLESCH, IEA ;
HESS, JH ;
HUANG, S ;
AGUET, M ;
ROTHE, J ;
BLUETHMANN, H ;
KAUFMANN, SHE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (05) :1615-1621
[8]   THE MICROBICIDAL ACTIVITY OF INTERFERON-GAMMA-TREATED MACROPHAGES AGAINST TRYPANOSOMA-CRUZI INVOLVES AN L-ARGININE-DEPENDENT, NITROGEN OXIDE-MEDIATED MECHANISM INHIBITABLE BY INTERLEUKIN-10 AND TRANSFORMING GROWTH-FACTOR-BETA [J].
GAZZINELLI, RT ;
OSWALD, IP ;
HIENY, S ;
JAMES, SL ;
SHER, A .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (10) :2501-2506
[9]  
GAZZINELLI RT, 1994, J IMMUNOL, V153, P2533
[10]  
GREEN SJ, 1990, J IMMUNOL, V144, P278